Search results for "taxi"

showing 10 items of 515 documents

An updated overview of the marine alien and cryptogenic species from the Egadi Islands Marine Protected Area (Italy)

2016

An updated overview of the marine alien and cryptogenic species recorded in the Egadi Islands Marine Protected Area (Tyrrhenian Sea, Italy), based on relevant publications, grey literature and unpublished data, is presented and discussed. Altogether, 17 species (14 aliens and 3 cryptogenic) belonging to five taxa are present in the area: Rhodophyta (Antithamnionella elegans, Asparagopsis armata, Asparagopsis taxiformis, Bonnemaisonia hamifera, Botryocladia madagascariensis, Ceramium strobiliforme, Laurencia caduciramulosa, Lophocladia lallemandii, Neosiphonia harveyi, Womersleyella setacea), Chlorophyta (Caulerpa cylindracea and Caulerpa taxifolia), Mollusca (Aplysia dactylomela), Arthropod…

0106 biological sciencesbiologyAsparagopsis armataEcologySettore BIO/02 - Botanica Sistematica010604 marine biology & hydrobiologyCaulerpa taxifoliaMarine reserveBonnemaisonia hamiferaAquatic ScienceOceanographybiology.organism_classification010603 evolutionary biology01 natural sciencesPercnon gibbesiEgadi Islands Marine Protected Area Italy Mediterranean Sea Review Marine alien and cryptogenic speciesSettore BIO/03 - Botanica Ambientale E ApplicataMarine protected areaAsparagopsis taxiformisCryptogenic speciesEcology Evolution Behavior and SystematicsMarine Biodiversity
researchProduct

Distribution of Caulerpa taxifolia var. distichophylla (Sonder) Verlaque, Huisman & Procaccini in the Mediterranean Sea

2019

The Non-Indigenous Species (NIS) Caulerpa taxifolia var. distichophylla (Sonder) Verlaque, Huisman & Procaccini has been reported for the first time in the Mediterranean Sea along the coast of South Turkey. This NIS is actively expanding into the Eastern and Western Mediterranean Sea. In this paper, we present an overview of the current distribution of this alga in the Mediterranean Sea, based on relevant scientific publications, grey literature and personal observations. New records from the Sicilian coast (Italy) are also reported. Caulerpa taxifolia var. distichophylla was found over a wide range of environmental conditions (depth, light and substratum), suggesting a broad ecolog…

0106 biological scienceslcsh:QH1-199.5Caulerpa taxifoliaDistribution (economics)lcsh:General. Including nature conservation geographical distribution010603 evolutionary biology01 natural sciencesCaulerpa taxifolia var. distichophyllaMediterranean sealcsh:QH540-549.5Mediterranean SeaNon-Indigenous species (NIS) Caulerpa taxifolia var. distichophylla Sicily coast artificial marine infrastructures Mediterranean SeaNon-Indigenous species (NIS) Caulerpa taxifolia var. distichophylla Sicily coast artificial marine infra- structures Mediterranean SeaNature and Landscape Conservationbiologybusiness.industry010604 marine biology & hydrobiologySettore BIO/02 - Botanica SistematicaSicily coastbiology.organism_classificationartificial marine infrastructuresGeographyOceanographySettore BIO/03 - Botanica Ambientale E ApplicataNon-Indigenous species (NIS)lcsh:Ecologybusiness
researchProduct

Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations.

2015

Abstract GATA2 deficiency—formerly described as MonoMAC syndrome; dendritic cells, monocytes, B cells, and natural killer cell deficiency; familial myelodysplastic syndrome/acute myeloid leukemia; or Emberger syndrome—encompasses a range of hematologic and nonhematologic anomalies, mainly characterized by monocytopenia, B lymphopenia, natural killer cell cytopenia, neutropenia, immunodeficiency, and a high risk of developing acute myeloid leukemia. Herein, we present 7 patients with GATA2 deficiency recruited into the French Severe Chronic Neutropenia Registry, which enrolls patients with all kinds of congenital neutropenia. We performed extended immunophenotyping of their whole blood lymph…

0301 basic medicineAdultMaleReceptors CXCR4AdolescentLymphocyteT-LymphocytesImmunologyMonocytopeniaBiologyNatural killer cell03 medical and health sciencesYoung AdultImmunophenotypinghemic and lymphatic diseasesmedicineImmunology and AllergyHumansLymphocyte CountCongenital NeutropeniaChildAgedCytopeniaB-LymphocytesGATA2 DeficiencyTraditional medicineChemotaxisCell MembraneMyeloid leukemiaCell Biologymedicine.diseaseCD56 AntigenChemokine CXCL12GATA2 Transcription FactorKiller Cells Natural030104 developmental biologymedicine.anatomical_structureImmunologyMutationFemaleJournal of leukocyte biology
researchProduct

New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients

2017

Abstract Introduction The diagnosis aceruloplasminemia is usually made in patients with advanced neurological manifestations of the disease. In these patients prognosis is poor, disabilities are severe and patients often die young. The aim of our study was to facilitate recognition of aceruloplasminemia at a disease stage at which treatment can positively influence outcome. Currently, the neurological phenotype of aceruloplasminemia has been mainly described in Japanese patients. This ‘classical’ phenotype consists of cerebellar ataxia, hyperkinetic movement disorders and cognitive decline. In this study we describe the spectrum of neurological disease in Caucasian patients. Methods Data on…

0301 basic medicineAdultMalemedicine.medical_specialtyPediatricsAtaxiaMovement disordersBiologyWhite People03 medical and health sciencesNeurological manifestation0302 clinical medicinePhenotypic variabilitymedicineAceruloplasminemiaHumansCognitive declineAceruloplasminemiaPsychiatryDystoniaCerebellar ataxiaParkinsonismCeruloplasminChoreaNeurodegenerative DiseasesMiddle Agedmedicine.diseaseIron Metabolism DisordersPedigree030104 developmental biologyPsychiatric changesPhenotypeNeurologyFemaleNeurology (clinical)Geriatrics and Gerontologymedicine.symptomNervous System DiseasesSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' Motorie030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications

2021

Cholesterol, an essential component of the brain, and its local metabolism are involved in many neurodegenerative diseases. The blood-brain barrier is impermeable to cholesterol; hence, cholesterol homeostasis in the central nervous system represents a balance betweenin situbiosynthesis and elimination. Cytochrome P450 46A1 (CYP46A1), a central nervous system-specific enzyme, converts cholesterol to 24-hydroxycholesterol, which can freely cross the blood-brain barrier and be degraded in the liver. By the dual action of initiating cholesterol efflux and activating the cholesterol synthesis pathway, CYP46A1 is the key enzyme that ensures brain cholesterol turnover. In humans and mouse models,…

0301 basic medicineAgingCognitive Neuroscience24-hydroxycholesterolbrain[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyCentral nervous systemNeurosciences. Biological psychiatry. NeuropsychiatryReview03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineneurodegenerative diseasesAmyotrophic lateral sclerosisLipid raftlipid raftsbiologyCholesterolbusiness.industryphosphorylation[SDV.NEU.NB] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyCytochrome P450cholesterolmedicine.diseaseplasma membranes3. Good healthVesicular transport proteinCYP46A1030104 developmental biologymedicine.anatomical_structurechemistrySpinocerebellar ataxiabiology.proteinAnimal studiesbusinessNeuroscience030217 neurology & neurosurgeryNeuroscienceRC321-571
researchProduct

Human exceptional longevity: transcriptome from centenarians is distinct from septuagenarians and reveals a role of Bcl-xL in successful aging.

2016

24 páginas, 7 figuras. Borras C, et al. Human exceptional longevity: transcriptome from centenarians is distinct from septuagenarians and reveals a role of Bcl-xL in successful aging. Aging (Albany NY). 2016 Oct 28;8(12):3185-3208. doi: 10.18632/aging.101078.

0301 basic medicineAgingFAS ligandmedia_common.quotation_subjectBiologíaLongevitybcl-X ProteinBcl-xLPeripheral blood mononuclear cellFas ligandTranscriptome03 medical and health sciences0302 clinical medicineAnimalsHumansBcl-2RNA MessengerCaenorhabditis elegansmedia_commonAgedGeneticsAged 80 and overSuccessful agingbiologyLongevityapoptosisCell BiologyGenéticaUp-RegulationRNA; apoptosis030104 developmental biologyhealthy agingGene Expression RegulationApoptosis030220 oncology & carcinogenesisbiology.proteinRNATranscriptomeLeukocyte chemotaxisResearch Paper
researchProduct

PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia

2020

Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is characterized by degeneration of the large sensory neurons and spinocerebellar tracts, cardiomyopathy, and increased incidence in diabetes. The underlying pathophysiological mechanism of FRDA, driven by a significantly decreased expression of frataxin (FXN), involves increased oxidative stress, reduced activity of enzymes containing iron‑sulfur clus-ters (ISC), defective energy production, calcium dyshomeostasis, and impaired mitochondrial biogenesis, leading to mitochondrial dysfunction. The peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated transcriptional factor playing a key role in mito…

0301 basic medicineAtaxiaCell SurvivalCaspase 3PPAR agonistlcsh:RC321-57103 medical and health sciencesMice0302 clinical medicineIron-Binding ProteinsmedicineNeuritesAnimalsHumansMyocytes CardiacNeurodegenerationDorsal root ganglia neuronslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryMembrane Potential MitochondrialNeuronsCardiomyocytesbiologyChemistryFrataxinNeurodegenerationCalpainLipid DropletsPeroxisomemedicine.diseaseCell biologyMitochondriaRatsPPAR gamma030104 developmental biologyNeurologyMitochondrial biogenesisFriedreich AtaxiaFrataxinbiology.proteinThiazolidinedionesmedicine.symptomMitochondrial function030217 neurology & neurosurgery
researchProduct

Oxidative stress modulates rearrangement of endoplasmic reticulum-mitochondria contacts and calcium dysregulation in a Friedreich's ataxia model

2020

Friedreich ataxia (FRDA) is a neurodegenerative disorder characterized by neuromuscular and neurological manifestations. It is caused by mutations in the FXN gene, which results in loss of the mitochondrial protein frataxin. Endoplasmic Reticulum-mitochondria associated membranes (MAMs) are inter-organelle structures involved in the regulation of essential cellular processes, including lipid metabolism and calcium signaling. In the present study, we have analyzed in both, unicellular and multicellular models of FRDA, calcium management and integrity of MAMs. We observed that function of MAMs is compromised in our cellular model of FRDA, which was improved upon treatment with antioxidants. I…

0301 basic medicineAtaxiaClinical BiochemistryLipid peroxidationchemistry.chemical_elementMitochondrionCalciumEndoplasmic ReticulumBiochemistry03 medical and health sciences0302 clinical medicineMAMsmedicineAnimalsVitamin EMitochondrial calcium uptakelcsh:QH301-705.5Calcium signalinglcsh:R5-920biologyFrataxinEndoplasmic reticulumOrganic ChemistryN-acetylcysteineMitochondriaCell biologyOxidative StressDrosophila melanogaster030104 developmental biologychemistrylcsh:Biology (General)Friedreich AtaxiaFrataxinbiology.proteinCalciummedicine.symptomCellular modellcsh:Medicine (General)030217 neurology & neurosurgeryResearch PaperRedox Biology
researchProduct

2018

Drosophila melanogaster has been for over a century the model of choice of several neurobiologists to decipher the formation and development of the nervous system as well as to mirror the pathophysiological conditions of many human neurodegenerative diseases. The rare disease Friedreich’s ataxia (FRDA) is not an exception. Since the isolation of the responsible gene more than two decades ago, the analysis of the fly orthologue has proven to be an excellent avenue to understand the development and progression of the disease, to unravel pivotal mechanisms underpinning the pathology and to identify genes and molecules that might well be either disease biomarkers or promising targets for therap…

0301 basic medicineAtaxiaDiseaseCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicinemedicineDisease biomarkerPhysical and Theoretical ChemistryMolecular BiologyDrosophilaSpectroscopybiologyOrganic ChemistryGeneral Medicinebiology.organism_classificationPhenotype3. Good healthComputer Science Applications030104 developmental biologyFrataxinbiology.proteinmedicine.symptomDrosophila melanogasterNeuroscience030217 neurology & neurosurgeryGenetic screenInternational Journal of Molecular Sciences
researchProduct

Reversible Axonal Dystrophy by Calcium Modulation in Frataxin-Deficient Sensory Neurons of YG8R Mice

2017

15 Pages, 8 Figures. The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fnmol.2017.00264/full#supplementary-material

0301 basic medicineAtaxiaNeuriteFriedreich’s ataxiarare diseaseMitochondrionlcsh:RC321-57103 medical and health sciencesCellular and Molecular Neurosciencechemistry.chemical_compound0302 clinical medicineBAPTAmedicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryMolecular BiologyOriginal ResearchcalciumbiologyNeurodegenerationneurodegenerationFriedreich's ataxiaaxonal spheroidsmedicine.disease3. Good healthmitochondria030104 developmental biologyPeripheral neuropathychemistrynervous systemFrataxinbiology.proteinAxoplasmic transportmedicine.symptomNeuroscience030217 neurology & neurosurgeryNeuroscience
researchProduct